GRAFT VERSUS HOST DISEASE
Clinical trials for GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo for Graft-Versus-Host disease fails to enroll
Disease control TerminatedThis study tested a mix of drugs (cyclophosphamide, sirolimus, low-dose IL-2, and azacitidine) to treat severe graft-versus-host disease that didn't respond to steroids. Only 3 patients were enrolled before the trial was stopped early. The goal was to see if the treatment could c…
Matched conditions: GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Light therapy study sheds light on immune changes in transplant complication
Knowledge-focused TerminatedThis study looked at how extracorporeal photopheresis (ECP) — a treatment that uses light to modify a patient's own blood cells — affects the immune system in people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Only 8 people were en…
Matched conditions: GRAFT VERSUS HOST DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC